Protein kinase activity is associated with CD63 in melanoma cells

Journal of Translational Medicine

Volumn 3, Issue , 2005, Pages

  Iida, Joji ^a   Skubitz, Amy P N ^a   McCarthy, James B ^a   Skubitz, Keith M ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD63 ANTIGEN; CHELERYTHRINE; GENISTEIN; PHOSPHOAMINO ACID; PROTEIN KINASE; PROTEIN SERINE KINASE;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN FUNCTION; ARTICLE; CELL ADHESION; CELL ASSAY; CELL FUNCTION; CELL STIMULATION; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ANALYSIS; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; ISOTOPE LABELING; MELANOMA CELL; MICROTITER PLATE ASSAY; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 29144439272     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-3-42     Document Type: Article

References (45)

1. Metzelaar MJ, Wijngaard PLJ, Peters PJ, Sixma JJ, Nieuwenhuis HK, Clevers HC: CD63 Antigen. J Biol Chem 1991, 266(5):3239-3245.
2. Azorsa DO, Hyman JA, Hildreth JEK: CD63/Pltgp40: A platelet activation antigen identical to the stage-specific, melanoma-associated antigen ME491. Blood 1991, 78(2):280-284.
3. Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, Ricciardi RP, Tsujimoto Y, Croce CM, Koprowski H: Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 1988, 48(11):2955-2962.
4. Hotta H, Miyamoto H, Hard I, Takahashi N, Homma M: Genomic structure of the ME491/CD63 antigen gene and functional analysis of the 5′-flanking regulatory sequences. Biochem Biophys Res Commun 1992, 185(1):436-442.
5. Nishikata H, Oliver C, Mergenhagen SE, Siraganian RP: The rat mast cell antigen AD1 (homologue to human CD63 or melanoma antigen ME491) is expressed in other cells in culture. J Immunol 1992, 149(3):862-870.
6. Kondoh M, Ueda M, Ichihashi M, Mishima Y: Decreased expression of human melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to invasive and metastatic melanomas. Melanoma Res 1993, 3(4):241-245.
7. Atkinson B, Ernst CS, Ghrist BF, Ross AH, Clark WH, Herlyn M, Herlyn D, Maul G, Steplewski Z, Koprowski H: Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. Hybridoma 1985, 4(3):243-255.
8. Sikora LK, Pinto A, Demetrick DJ, Dixon WT, Urbanski SJ, Temple W, Jerry LM: Characterization of a novel neuroglandular antigen (NGA) expressed on abnormal human melanocytes. Int J Cancer 1987, 39(2):138-145.
9. Metzelaar MJ, Schuurman H-J, Heijnen HFG, Sixma JJ, Nieuwenhuis HK: Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies. Virchows Archiv (Berlin) 1991, 61(4):269-277.
10. Nieuwenhuis HK, van Oosterhout JJG, Rozemuller E, van Iwaarden F, Sixma JJ: Studies with a monoclonal antibody against activated platelets: Evidence that a secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood 1987, 70(3):838-845.
11. Knol EF, Mul FPJ, Jansen H, Calafat J, Roos D: Monitoring human basophil activation via CD63 monoclonal antibody 435. J Allergy Clin Immunol 1991, 88:328-338.
12. Peters PJ, Borst J, Oorschot V, Fukuda M, Krahenbuhl O, Tschopp J, Slot JW, Geuze HJ: Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes. J Exp Med 1991, 173(5):1099-1109.
13. Kuijpers TW, Tool ATJ, van der Schoot EC, Ginsel LA, Onderwater JJM, Roos DV, A. J.: Membrane surface antigen expression on neutrophils: A reappraisal of the use of surface markers-for neutrophils activation. Blood 1991, 78(4):1105-1111.
14. Horejsí V, Vlcek C: Novel structurally distinct family of leucocyte surface glycoproteins including CD9, CD37, CD53, and CD63. FEBS Lett 1991, 288:1-4.
15. Skubitz KM, Campbell KD, Iida J, Skubitz APN: CD63 associates with tyrosine kinase activity and CD11/CD18, and transmits an activation signal in neutrophils. Journal of Immunology 1996, 157(8):3617-3626.
16. Vischer UM, Wagner DD: CD63 is a component of Weibel-Palade bodies of human endothelial cells. Blood 1993, 82(4):1184-1191.
17. Toothill VJ, van Mourik JA, Niewenhuis HK, Metzelaar MJ, Pearson JD: Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. J Immunol 1990, 145(1):283-291.
18. Nishibori M, Cham B, McNicol A, Shalev A, Jain N, Gerrard JM: The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. J Clin Invest 1993, 91(4):1775-1782.
19. Hotta H, Hara I, Miyamoto H, Homma M: Overexpression of the human melanoma-associated antigen ME491 partially suppresses in vivo malignant phenotypes of H-ras-transformed NIH3T3 cells in athymic nude mice. Melanoma Res 1991, 1(2):125-132.
20. Radford KJ, Mallesch J, Hersey P: Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). Int J Cancer 1995, 62(5):631-635.
21. Radford KJ, Thorne RF, Hersey P: Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. J Immunol 1997, 158(7):3353-3358.
22. Jang HI, Lee H: A decrease in the expression of CD63 tetraspanin protein elevates invasive potential of human melanoma cells. Exp Mol Med 2003, 35(4):317-323.
23. Azorsa DO, Hildreth JEK: CD63 cluster workshop report. In: Leucocyte Typing V. Oxford University Press, Oxford, England; 1995: 1352.
24. Fukuda M: Lysosomal membrane glycoproteins. J Biol Chem 1991, 266(32):21327-21330.
25. Imai T, Fukudome K, Takagi S, Nagira M, Furuse M, Fukuhara N, Nishimura M, Hinuma Y, Yoshie O: CD33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 1992, 149(9):2879-2886.
26. Fidler IJ: Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Rev 1986, 5(1):29-49.
27. Skubitz KM, Campbell, K.D., and Skubitz, A.P.N.: Analysis of the Myeloid Panel of Monoclonal Antibodies by Immunoprecipitation, Immunoblotting, and Flow Cytometry. Oxford: Oxford University Press; 1995.
28. Bumol TF, Reisfeld RA: Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci U S A 1982, 79(4):1245-1249.
29. Iida J, Meijne AM, Spiro RC, Roos E, Furcht LT, McCarthy JB: Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated, proteoglycan (NG2) and alpha 4 beta 1 integrin. Cancer Res 1995, 55(10):2177-2185.
30. Skubitz KM, Snook RW, II.: Monoclonal antibodies that recognize lacto-N-fucopenatose III (CD15) react with adhesion-promoting glycoprotein family (LFA-1/HMAC-1/GP 150,95) and CR1 on human neutrophils. J Immunol 1987, 139:1631-1639.
31. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
32. Munoz G, Marshall SH: An alternative method for a fast separation of phosphotyrosine. Anal Biochem 1990, 190(2):233-237.
33. Skubitz KM, Goueli SA: CD31 (PECAM-1), CDw32 (Fc gamma RII), and anti-HLA class I monoclonal antibodies recognize phosphotyrosine-containing proteins on the surface of human neutrophils. J Immunol 1994, 152(12):5902-5911.
34. Herbert JM, Augereau JM, Gleye J, Maffrand JP: Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun 1990, 172(3):993-999.
35. Skubitz KM, Hammerschmidt DE: Corticosteroids reversibly inhibit chemotactic peptide-receptor binding and granulocyte response, yet allow desensitization and receptor down- regulation. Blood 1986, 68(4):830-836.
36. O'Flaherty JT, Kreutzer DL, Showell HS, Becker EL, Ward PA: Desensitization of the neutrophil aggregation response to chemotactic factors. Am J Pathol 1978, 93(3):693-706.
37. Lagaudriere-Gesbert C, Le Naour F, Lebel-Binay S, Billard M, Lemichez E, Boquet P, Boucheix C, Conjeaud H, Rubinstein E: Functional analysis of four tetraspans, CD9, CD53, CD81, and CD82, suggests a common role in costimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol 1997, 182(2):105-112.
38. Lazo PA, Cuevas L, Gutierrez del Arroyo A, Orue E: Ligation of CD53/OX44, a tetraspan antigen, induces homotypic adhesion mediated by specific cell-cell interactions. Cell Immunol 1997, 178(2):132-140.
39. Masellis-Smith A, Jensen GS, Seehafer JG, Slupsky JR, Shaw AR: Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J Immunol 1990, 144(5): 1607-1613.
40. Eisenmann KM, McCarthy JB, Simpson MA, Keely PJ, Guan JL, Tachibana K, Lim L, Manser E, Furcht LT, Iida J: Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol 1999, 1(8):507-513.
41. Israels SJ, McMillan-Ward EM: CD63 modulates spreading and tyrosine phosphorylation of platelets on immobilized fibrinogen. Thromb Haemost 2005, 93(2):311-318.
42. Berditchevski F, Bazzoni G, Hemler ME: Specific association of CD63 with the VLA-3 and VLA-6 integrins. J Biol Chem 1995, 270(30):17784-17790.
43. Berditchevski F, Tolias KF, Wong K, Carpenter CL, Hemler ME: A novel link between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and phosphatidylinositol 4-kinase. J Biol Chem 1997, 272(5):2595-2598.
44. Berditchevski F, Odintsova E: Characterization of integrin-tetraspanin adhesion complexes: role of tetraspanins in integrin signaling. J Cell Biol 1999, 146(2):477-492.
45. Radford KJ, Thorne RF, Hersey P: CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma. Biochem Biophys Res Commun 1996, 222:13-18.